Two Sigma Investments, LP Phathom Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$42.8 Billion
Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 97,327 shares of PHAT stock, worth $421,425. This represents 0.0% of its overall portfolio holdings.

Number of Shares

97,327

Previous 485,790 79.97%

Holding current value

$421,425

Previous $3.94 Million 84.53%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$4.22 - $7.74 $1.64 Million - $3.01 Million	-388,463 Reduced 79.97%	97,327 $610,000
Q4 2024 Feb 14, 2025	BUY	$7.45 - $18.94 $2.47 Million - $6.28 Million	331,760 Added 215.39%	485,790 $3.94 Million
Q3 2024 Nov 14, 2024	SELL	$10.25 - $19.5 $1.53 Million - $2.91 Million	-149,401 Reduced 49.24%	154,030 $2.78 Million
Q2 2024 Aug 14, 2024	SELL	$8.97 - $12.05 $1.47 Million - $1.98 Million	-164,017 Reduced 35.09%	303,431 $3.13 Million
Q1 2024 May 15, 2024	BUY	$6.21 - $11.05 $1.25 Million - $2.22 Million	200,591 Added 75.17%	467,448 $4.96 Million
Q4 2023 Feb 14, 2024	BUY	$6.99 - $10.71 $1.28 Million - $1.96 Million	182,794 Added 217.45%	266,857 $2.44 Million
Q3 2023 Nov 14, 2023	BUY	$10.26 - $15.7 $436,696 - $668,239	42,563 Added 102.56%	84,063 $871,000
Q2 2023 Aug 14, 2023	BUY	$7.28 - $14.32 $90,272 - $177,568	12,400 Added 42.61%	41,500 $594,000
Q1 2023 May 15, 2023	BUY	$6.19 - $12.36 $180,129 - $359,676	29,100 New	29,100 $207,000
Q2 2022 Aug 15, 2022	SELL	$6.2 - $15.5 $30,454 - $76,136	-4,912 Reduced 12.21%	35,304 $298,000
Q1 2022 May 16, 2022	SELL	$11.55 - $20.06 $272,349 - $473,014	-23,580 Reduced 36.96%	40,216 $547,000
Q4 2021 Feb 14, 2022	BUY	$17.83 - $33.15 $735,327 - $1.37 Million	41,241 Added 182.85%	63,796 $1.26 Million
Q3 2021 Nov 15, 2021	SELL	$30.69 - $36.83 $534,896 - $641,910	-17,429 Reduced 43.59%	22,555 $724,000
Q2 2021 Aug 16, 2021	SELL	$32.66 - $39.87 $479,154 - $584,932	-14,671 Reduced 26.84%	39,984 $1.35 Million
Q1 2021 May 17, 2021	BUY	$33.86 - $48.68 $1.85 Million - $2.66 Million	54,655 New	54,655 $2.05 Million

Others Institutions Holding PHAT

# of Institutions

152

Shares Held

66.6M

Call Options Held

94K

Put Options Held

55.5K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $170M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Phathom Pharmaceuticals, Inc. Transaction History